Toremifene works by antagonizing estrogen receptors in breast tissue. Estrogen can promote the growth of breast cancer cells by binding to its receptors on the cell surface. By blocking these receptors, toremifene reduces the proliferative effects of estrogen, thereby slowing or halting the progression of the disease. Its mechanism of action is similar to that of tamoxifen, another well-known SERM.
